8-31096778-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BS1_Supporting
The NM_000553.6(WRN):c.1909C>T(p.Arg637Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000368 in 1,609,108 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00033 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00037 ( 1 hom. )
Consequence
WRN
NM_000553.6 missense
NM_000553.6 missense
Scores
2
5
12
Clinical Significance
Conservation
PhyloP100: 1.43
Genes affected
WRN (HGNC:12791): (WRN RecQ like helicase) This gene encodes a member of the RecQ subfamily of DNA helicase proteins. The encoded nuclear protein is important in the maintenance of genome stability and plays a role in DNA repair, replication, transcription and telomere maintenance. This protein contains a N-terminal 3' to 5' exonuclease domain, an ATP-dependent helicase domain and RQC (RecQ helicase conserved region) domain in its central region, and a C-terminal HRDC (helicase RNase D C-terminal) domain and nuclear localization signal. Defects in this gene are the cause of Werner syndrome, an autosomal recessive disorder characterized by accelerated aging and an elevated risk for certain cancers. [provided by RefSeq, Aug 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BS1
Variant frequency is greater than expected in population mid. gnomad4_exome allele frequency = 0.000372 (543/1459272) while in subpopulation MID AF= 0.00399 (23/5764). AF 95% confidence interval is 0.00273. There are 1 homozygotes in gnomad4_exome. There are 271 alleles in male gnomad4_exome subpopulation. Median coverage is 33. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WRN | NM_000553.6 | c.1909C>T | p.Arg637Trp | missense_variant | 17/35 | ENST00000298139.7 | NP_000544.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WRN | ENST00000298139.7 | c.1909C>T | p.Arg637Trp | missense_variant | 17/35 | 1 | NM_000553.6 | ENSP00000298139.5 | ||
WRN | ENST00000521620.5 | n.542C>T | non_coding_transcript_exon_variant | 5/23 | 1 | |||||
WRN | ENST00000650667.1 | n.*1523C>T | non_coding_transcript_exon_variant | 16/34 | ENSP00000498593.1 | |||||
WRN | ENST00000650667.1 | n.*1523C>T | 3_prime_UTR_variant | 16/34 | ENSP00000498593.1 |
Frequencies
GnomAD3 genomes AF: 0.000321 AC: 48AN: 149736Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
48
AN:
149736
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000412 AC: 103AN: 249788Hom.: 0 AF XY: 0.000392 AC XY: 53AN XY: 135134
GnomAD3 exomes
AF:
AC:
103
AN:
249788
Hom.:
AF XY:
AC XY:
53
AN XY:
135134
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000372 AC: 543AN: 1459272Hom.: 1 Cov.: 33 AF XY: 0.000373 AC XY: 271AN XY: 726072
GnomAD4 exome
AF:
AC:
543
AN:
1459272
Hom.:
Cov.:
33
AF XY:
AC XY:
271
AN XY:
726072
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000327 AC: 49AN: 149836Hom.: 0 Cov.: 31 AF XY: 0.000316 AC XY: 23AN XY: 72888
GnomAD4 genome
AF:
AC:
49
AN:
149836
Hom.:
Cov.:
31
AF XY:
AC XY:
23
AN XY:
72888
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
2
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
7
ExAC
AF:
AC:
44
Asia WGS
AF:
AC:
1
AN:
3476
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:5Benign:1Other:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jan 27, 2016 | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The WRN p.Arg637Trp variant was identified in 1 of 18 Werner syndrome patients; the variant was identified as a compound heterozygous mutation in a male with Werner syndrome, osteoporosis and cancer (Uhrhammer_2006_PMID:16786514). The variant was identified in dbSNP (ID: rs148286708) and ClinVar (classified as uncertain significance by EGL Genetic Diagnotics and Invitae) but was not identified in Cosmic or LOVD 3.0. The variant was identified in control databases in 111 of 279850 chromosomes (0 homozygous) at a frequency of 0.0003966 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: Ashkenazi Jewish in 7 of 10332 chromosomes (freq: 0.000678), European (non-Finnish) in 79 of 128100 chromosomes (freq: 0.000617), Other in 4 of 7152 chromosomes (freq: 0.000559), Latino in 17 of 35294 chromosomes (freq: 0.000482), South Asian in 3 of 30544 chromosomes (freq: 0.000098) and European (Finnish) in 1 of 23934 chromosomes (freq: 0.000042), but was not observed in the African or East Asian populations. The p.Arg637 residue is conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. - |
Werner syndrome Uncertain:1Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
not specified Uncertain:1Other:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Jun 15, 2021 | DNA sequence analysis of the WRN gene demonstrated a sequence change, c.1909C>T, in exon 17 that results in an amino acid change, p.Arg637Trp. This sequence change has been described in gnomAD with a frequency of 0.062% in Non-Finnish European sub-population (dbSNP rs148286708). The p.Arg637Trp change affects a highly conserved amino acid residue located in a domain of the WRN protein that is known to be functional. In-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL) provide contradictory results for the p.Arg637Trp substitution. This particular sequence change has been reported in the compound heterozygous state in one individual with Werner syndrome, osteoporosis, and cancer (PMID: 16786514). Due to the lack of sufficient evidences, the clinical significance of the p.Arg637Trp change remains unknown at this time. - |
not provided, no classification provided | reference population | ITMI | Sep 19, 2013 | - - |
WRN-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 19, 2023 | The WRN c.1909C>T variant is predicted to result in the amino acid substitution p.Arg637Trp. This variant was reported in the compound heterozygous state in an individual with Werner syndrome; however no functional or family segregation studies have confirmed its pathogenicity (Patient 943-1, Uhrhammer et al. 2006. PubMed ID: 16786514). This variant was also reported in an individual with head and neck cancer (Table S3, Cury et al. 2021. PubMed ID: 34598035) and an individual with osteosarcoma (eTable 5, Mirabello et al. 2020. PubMed ID: 32191290). This variant is reported in 0.068% of alleles in individuals of Ashkenazi Jewish descent in gnomAD. In ClinVar, this variant has conflicting interpretations of pathogenicity ranging from benign to uncertain significance (https://www.ncbi.nlm.nih.gov/clinvar/variation/135421). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Uncertain
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
M_CAP
Benign
T
MetaRNN
Uncertain
D
MetaSVM
Benign
T
MutationAssessor
Pathogenic
M
PrimateAI
Benign
T
PROVEAN
Pathogenic
D
REVEL
Benign
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
D
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at